Delivery Order SPE2DB22D1017-SPE2DB24FF3ZC
- Not listed
- This federal contract award, with an ID of SPE2DB22D1017|SPE2DB23FF6JU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $12,052.03 and a completion date of May 2, 2023. The contract is a Delivery Order type, with a Firm Fixed Price pricing structure. It is not designated as a Set-Aside contract. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $10,229.24 and a completion date of July 22, 2024. This is a delivery order contract with a firm fixed price pricing type, and there is no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver BIKTARVY 50-200-25 MG TABLET medical products. The $15,445.01 firm-fixed-price delivery order has a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $17,632.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a prescription medication, with a completion date of January 12, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $10,773.73 delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the provision of BIKTARVY 50-200-25 MG TABLET in quantities of 30 under a Delivery Order contract valued at $29,074.78. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 24, 2024. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $68,493.14 delivery order contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of September 28, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, with the ID SPE2DB22D3004|SPE2DB24FPH72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S, with a ceiling value of $17,859.42 and a completion date of February 15, 2024. The contract is a firm fixed-price award without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $7,383.22 and a completion date of June 12, 2024. This contract is a delivery order, with a firm fixed-price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30 each, with a ceiling value of $7,145.55 and a performance period ending on May 20, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not set aside for any special program. Amerisourcebergen Drug Corp is the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3ZCDelivery Order
This federal contract award, with an ID of SPE2DB22D1017|SPE2DB24FF3ZC, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $10,445.69 and an ultimate completion date of March 11, 2024. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 3/8/24 |